Management of scleroderma-related end-stage renal disease with automated peritoneal dialysis
IJKD-Iranian Journal of Kidney Diseases. 2010; 4 (2): 162-163
in English
| IMEMR
| ID: emr-105455
ABSTRACT
Kidney failure is the principal cause of death in scleroderma and accounts for at least 50% of deaths in this disease. Management of scleroderma-related end-stage renal disease requires some form of renal replacement therapy. Survival up to 18 months has been reported in one patient on continuous ambulatory peritoneal dialysis. Surviving for more than 1 year on automated peritoneal dialysis has not been reported. We report a patient with scleroderma-related end-stage renal disease treated with automated peritoneal dialysis with steady state control of uremia and hypertension at 18 months of follow-up
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Sclerosis
/
Uremia
/
Peritoneal Dialysis
/
Peritoneal Dialysis, Continuous Ambulatory
/
Renal Replacement Therapy
/
Scleroderma, Diffuse
/
Kidney Failure, Chronic
Type of study:
Case report
Limits:
Female
/
Humans
Language:
English
Journal:
Iran. J. Kidney Dis.
Year:
2010
Similar
MEDLINE
...
LILACS
LIS